Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/1862
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | OKONTA, Emeka M | - |
dc.date.accessioned | 2024-06-13T08:28:06Z | - |
dc.date.available | 2024-06-13T08:28:06Z | - |
dc.date.issued | 2020-09-25 | - |
dc.identifier.issn | 2468-7391 | - |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/1862 | - |
dc.description.abstract | The coronavirus disease also known as COVID‑19 was discovered at the end of 2019 following epidemic of acute respiratory syndrome in humans in Wuhan, China. It leads to lung destruction at acute stage of the disease and, possibly, progressive lung destruction from extensive inflammatory process at the ground zero which is the lung. This will eventually lead to a permanent scaring of the lungs with reduction in the oxygenation of the lungs and eventually end‑stage lung disease. The use of ventilations and extracorporeal membrane oxygenation does not seem to hold the ace in guaranteeing a long‑term relieve, but lung transplant for the condition may be the solution in a long‑term basis. | en_US |
dc.language.iso | en | en_US |
dc.publisher | NIGERIAN JOURNAL OF CARDIOVASCULAR AND THORACIC SURGERY | en_US |
dc.relation.ispartofseries | Volume 4;No 2 | - |
dc.subject | COVID-19 | en_US |
dc.subject | Transplant | en_US |
dc.subject | Lungs | en_US |
dc.title | LUNG TRANSPLANT AFTER COVID-19, WOULD THERE BE A NEED FOR IT IN THE FUTURE | en_US |
dc.type | Article | en_US |
Appears in Collections: | Books |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
55LungtransplantandCOVID-19-2.pdf | 1.12 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.